Phenolic alkaloids from Menispermum dauricum inhibits BxPC-3 pancreatic cancer cells by blocking of Hedgehog signaling pathway
Zhong-guang Zhou1, Chao-ying Zhang2, Hong-xin Fei3, Li-li Zhong4, Yun Bai5
1 Research Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Heilongjiang, China
2 The Fourth Affiliated Hospital, Harbin Medical University, Heilongjiang, China
3 Research Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine; Department of Qiqihar Medical University, Basic Medicine, Heilongjiang, China
4 Department of Pathology, The First Affiliated Hospital, Heilongjiang, China
5 Basic Medical College, Heilongjiang University of Chinese Medicine, Heilongjiang, China
|Date of Submission||03-Dec-2014|
|Date of Acceptance||05-Feb-2015|
|Date of Web Publication||16-Sep-2015|
Department of Pathology, The First Affiliated Hospital, Heilongjiang University of Chinese Medicine
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: The Hedgehog (Hh) signaling pathway plays an important role in pancreatic cancer (PC) cells. Phenolic alkaloids from Menispermum dauricum (PAMD), a traditional Chinese medicine used for the treatment of immune disorders, have been reported to have antitumor activity recently. Objective: To investigate the efficacy and mechanism of PAMD against PC cell BxPC-3. Materials and Methods: F assay was used to assess cell proliferation inhibition of PAMD; the apoptotic induction and cell cycle arrest was detected by flow cytometry; the BxPC-3 xenograft was established to evaluate the tumor growth inhibition of PAMD; hematoxylin-eosin staining was applied to analyze the pathological morphology of tumor tissues; immunohistochemistry (IHC) and Western blot was adopted to detect the protein levels; quantitative real-time polymerase chain reaction was used to determine the mRNA expressions. Results: PAMD shows time-and dose-dependent proliferation inhibition on the BxPC-3 cell, induced G0/G1 phase arrest and cell apoptosis in vitro. PAMD also showed better inhibition of tumor growth and a preferable safety profile compared with chemotherapeutic regimen 5-fluoro-2, 4 (1 H, 3 H) pyrimidinedione in BxPC-3 xenograft in vivo. Furthermore, PAMD directly decreases the protein and mRNA levels of Sonic Hedgehog (Shh) and its downstream transcription factor Gli-1 in the BxPC-3 tumor tissues. Conclusion: The treatment of PAMD displayed Hh signaling pathway blockade through decreasing the protein and mRNA levels of Shh and its downstream transcription factor Gli-1, suggesting a promising strategy in treating human PC.
Keywords: BxPC-3, Gli-1, pancreatic cancer, phenolic alkaloids from Menispermum dauricum, Sonic Hedgehog
|How to cite this article:|
Zhou Zg, Zhang Cy, Fei Hx, Zhong Ll, Bai Y. Phenolic alkaloids from Menispermum dauricum inhibits BxPC-3 pancreatic cancer cells by blocking of Hedgehog signaling pathway. Phcog Mag 2015;11:690-7
|How to cite this URL:|
Zhou Zg, Zhang Cy, Fei Hx, Zhong Ll, Bai Y. Phenolic alkaloids from Menispermum dauricum inhibits BxPC-3 pancreatic cancer cells by blocking of Hedgehog signaling pathway. Phcog Mag [serial online] 2015 [cited 2021 Sep 21];11:690-7. Available from: http://www.phcog.com/text.asp?2015/11/44/690/165548
Zhong-guang Zhou, Chao-ying Zhang
These authors contributed equally to this work
| Introduction|| |
Pancreatic cancer (PC) is one of the most aggressive malignancies among the human cancers, and its overall 5 years survival is <5%. , The poor clinical prognosis may be due to the lack of early symptoms and reliable diagnostic markers for early detection.  Furthermore, apart from chemotherapy and radiation therapy, there are no effective therapies for the treatment of refractory PC.  Therefore, the development of novel therapeutic strategies is urgently required.
The Hedgehog (Hh) is an essential protein during embryonic development and adult stem cell function. ,, Its signaling is minimal in differentiated tissues of healthy adults,  and aberrant activated Hh has been detected in about 70% of pancreatic ductal adenocarcinomas (PDAC),  thus Hh has got a lot of attention as a critical target of PC. Sonic Hedgehog (Shh), a member of the Hh family, initiated the signaling pathway by binding to the Hh receptor Patched (Ptc) and removing the inhibition on the transmembrane protein Smothened,  thereby leading to the activation of the Gli transcription factors that control cell growth, survival, and differentiation in various tissues. ,,, Blockade of Hh pathway has been shown to inhibit PC cancer cell growth, invasion, and metastases. ,,, Recent studies demonstrated that inhibition of the Hh pathway induces autophagy in PDAC cells,  and combination with chemotherapy leads to tumor reduction in PC.  Therefore, the inhibition of Hh signaling pathway have been considered to be a potent strategy in PC therapies.
Phenolic alkaloids from Menispermum dauricum (PAMD), a traditional Chinese herb prescription with main constituents of daurisolin, dauricine, daurinoline and dauricicoline,  has been widely used for the treatment of immune disorders such as cardiovascular and thrombosis disorders for thousands of years.  Recent studies also show that PAMD has antitumor activity through inducing apoptosis and inhibiting the proliferation and invasion in colon and urinary cancer cells. , The aim of the present work is to study the tumor suppressive efficacy of PAMD, which shows potent anti-PC ability through blockade of Hh signaling pathway.
| Materials and methods|| |
Cell lines and reagents
Human PC cell line BxPC-3, obtained from Shanghai Institute of Biochemistry and Cell Biology, was maintained in RPMI-1640 (Gibco) medium supplemented with 10% fetal calf serum in a humidified atmosphere containing 5% CO 2 at 37°C.
Phenolic alkaloids from Menispermum dauricum was prepared as mentioned in,  by Prof. Wang Dong from Heilongjiang University of Chinese Medicine. Primary antibodies against Ki67, Shh and Gli-1 were purchased from Santa Cruz. 5-fluoro-25-fluoro-2, 4 (1 H, 3 H) pyrimidinedione (5-Fu), 1-(4, 5-Dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT) and trypsin were obtained from Sigma. SYBR Premix Ex Taq and PrimeScript RT kits were brought from Takara Company.
1-(4, 5-Dimethylthiazol-2-yl)-3,5-diphenylformazan assay
Cells (5 × 10 3 /well) were seeded into 96-well plates and treated with PAMD, 5-Fu or saline control. At the end of the incubation period, cell viability was assessed by MTT assay. Formazan crystals formed were solubilized in dimethyl sulfoxide, and the optical density of the resulting solution was recorded at 570 nm on a microplate reader (Thermo, USA).
Cell cycle analysis
Cells were seeded in 6-well plates and treated with PAMD, 5-Fu or saline for 24 h. The cells were harvested, washed with phosphate-buffered saline (PBS), and fixed with 70% ethanol at −20°C overnight. After an additional washing, cells were incubated with RNase A (20 μg/mL) at 37°C for 30 min, stained with propidium iodide (100 μg/mL; Sigma-Aldrich) for 10 min, and analyzed with flow cytometry (BD FACSC autoTM II).
Cells were seeded in 6-well plates and treated with PAMD, 5-Fu or saline for 24 h. Apoptosis was determined with the Annexin-V: FITC Apoptosis Detection Kit I (BD Biosciences) according to the manufacturer's protocol. Briefly, the saline control and drug-treated tumor cells were collected via centrifugation and washed once with PBS. The cells were subsequently stained with fluorescein and propidium iodide for 15 min at room temperature and analyzed with flow cytometry (BD FACSC autoTM II).
BALB/C nu/nu female mice, aged 4-6 weeks, weighing about 20 g, were obtained from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. BxPC-3 cells (1 × 10 7 , suspended in 200 μL of PBS) were implanted s. c. in the hind flank of each mouse. Once palpable tumors were established, animals were randomly divided into four groups so that all groups had similar starting mean tumor volumes of 100-150 mm 3 . The six mice in each group were injected intraperitoneally with the saline control, 5-Fu or PAMD. Tumor volumes were calculated using the following ellipsoid formula: (D × [d2])/2, in which D is the large diameter of the tumor, and d is the small diameter. Tumor growth inhibition was determined using the following formula: 100% × ([WC-WT]/WC), in which WC represents mean tumor weight of the saline group, and WT represents mean tumor weight of a treated group. Spleen index = mass of spleen (mg)/body weight of mouse (g). All animal experiments were approved by Animal Care and Use Committee, Heilongjiang University of Chinese Medicine, China.
Tumor tissues were taken out before fixed in 4% paraformaldehyde and embedded in paraffin. Paraffin sections were treated by dewaxing, dehydration, hematoxylin staining, hydrochloric acid ethanol differentiation, ammonia treatment, eosin staining, ethanol dehydration, transparentization, drying and gum mounting processes before optical microscope observation.
After fixation with formalin, tissues were embedded with paraffin, cut, and mounted on slides. Then, slides were washed with xylene to deparaffinize, with graded ethanol to rehydrate, incubated with citrate buffer to retrieve antigen and blocked with 3% H 2 O 2 to inactivate endogenous peroxidase. Slides were incubated with primary antibody at 4°C overnight, followed by incubation with horseradish peroxidase (HRP)-conjugated goat anti-rabbit secondary antibody for 30 min at room temperature. Complex visualization was done with a 2-solution DAB Kit (Invitrogen). Contrast was applied with hematoxylin, and the slides were mounted in Canadian balsam and observed with a light microscope.
Tumor tissue was homogenated with NP-40 lysis buffer (50 mmol/L Tris pH 8.0, 150 mmol/L NaCl, and 1% NP-40) at the proportion of 1 g/mL supplemented with phenylmethanesulfonyl fluoride (Sigma Aldrich) and PhosSTOP (Roche Diagnostics) at 4°C, and centrifuged at 12,000 × g for 10 min. The supernatant was collected as the total protein extract. Protein concentration was estimated using a Pierce BCA Protein Assay Kit (Thermo Scientific) according to the manufacturer's protocol. Equal amounts of protein were analyzed with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Thereafter, proteins were transferred to nitrocellulose membranes and blotted with specific primary antibodies. Proteins were detected via incubation with HRP-conjugated secondary antibodies. Results were recorded by Alpha image 2000 and analyzed by Image-Pro Plus.
Quantitative real-time polymerase chain reaction
Total RNA extraction of tumor tissue was performed with TRIzol reagent (Life Technologies Corporation), and first-strand cDNA was synthesized using 1 µg of total RNA (concentrations measured by NanoDrop 2000, Thermo Scientific) according to the manufacturer's instructions. Quantitative RT-PCR analysis was performed in triplicate with StepOnePlus RT-PCR system (Life Technologies). The ΔΔCT, two triangles+CT method was used to calculate relative expression. Primer sequences (synthesized by Shanghai Generay Biotech Co., Ltd.) used in RT-PCR for Shh (forward 5'- GCTCGGTGAAAGCAGAGAACT-3' and reverse 5'- CCCAGGAAAGTGAGGAAGTCG-3'), and Gli-1(forward 5'- ATCCTTACCTCCCAACCTCTGT-3' and reverse 5'- CCAACTTCTGGCTCTTCCTGTA-3'), using GAPDH (forward 5'-AGAAGGCTGGGGCTCATTTG-3' and reverse 5'- AGGGGCCATCCACAGTCTTC-3') as control.
Analysis of variance was used for comparisons across multiple groups. The data are reported as means ± standard deviation. Statistical analysis was performed using SPSS Statistics 19.0; (P < 0.05) was considered statistically significant.
| Results|| |
Phenolic alkaloids from Menispermum dauricum inhibits the proliferation of BxPC-3 pancreatic cancer cells
The effects of PAMD on cell proliferation were assessed with an MTT assay. The proliferation of BxPC-3 cells was markedly inhibited by PAMD and showed a time and dose-dependent manner, with IC 50 values of 2.37, 1.78 and 1.25 μg/mL for 24, 48 and 72 h, respectively [Figure 1].
|Figure 1: Phenolic alkaloids from Menispermum dauricum (PAMD) inhibits the proliferation of BxPC-3 pancreatic cancer cells. BxPC-3 pancreatic cancer cells were treated for (a) 24 h, (b) 48 h and (c) 72 h in the absence or presence of PAMD ranging from 1 to 32 ƒÊg/mL. Cell viability was measured with 1-(4, 5-Dimethylthiazol-2-yl)-3,5-diphenylformazan and expressed as a percentage of saline control. Results are presented as means ± standard deviation of three independent experiments. *P < 0.05: Significant difference; **P < 0.01: Very significant difference from control by analysis of variance. (d) The half maximal inhibitory concentrations (IC50) of PAMD against BxPC-3 for 24, 48 and 72 h, respectively|
Click here to view
Phenolic alkaloids from Menispermum dauricum induces BxPC-3 pancreatic cancer cells G0/G1 phase arrest and induces apoptosis
Compared to the control cells, PAMD-treated cells displayed obvious arrest of cell cycle in the G0/G1 phase after 24 h. The increase in the G0/G1 cell population was accompanied by a concomitant decrease in the population in the S and G2/M phases of the cell cycle, while the 5-Fu-treated groups showed an enhanced cell population in S phase, indicating the difference of anti-tumor mechanism [Figure 2]a and b], (P < 0.05).
|Figure 2: Phenolic alkaloids from Menispermum dauricum (PAMD) induces BxPC-3 pancreatic cancer cells G0/G1 phase arrest and induces apoptosis. (a) and (b) BxPC-3 cells were treated with PAMD, 5-fluoro-2, 4 (1 H, 3 H) pyrimidinedione (5-Fu) or saline for 24 h. The cells were then fixed with 70% ethanol at −20°C overnight, incubated with RNase A at 37°C for 30 min, stained with propidium iodide for 10 min, and analyzed with flow cytometry. (c) and (d) BxPC-3 cells were treated with PAMD, 5-Fu or saline for 24 h, and apoptotic cell death was detected by staining cells with an Annexin-V: FITC Apoptosis Detection Kit for analysis with flow cytometry|
Click here to view
BxPC-3 cells were treated with PAMD for 24 h and analyzed for apoptotic cell death using an Annexin-V: FITC Apoptosis Detection Kit. The results revealed a dose-dependent induction of apoptotic cell death by PAMD [Figure 2]c and d].
Phenolic alkaloids from Menispermum dauricum inhibits the tumor growth of BxPC-3 xenografts
BxPC-3 human PC xenografts were established to assess the chemotherapeutic potential of PAMD. The antitumor activity of PAMD were determined with the positive control of 20 mg/kg/day 5-Fu [Figure 3]a and b]. The results showed that PAMD exhibits better PC tumor suppression than 5-Fu, with tumor inhibition rates of 45.17% (P < 0.05) and 57.35% (P < 0.01) for 10 and 20 mg/kg 1 /day PAMD, while 41.38% (P < 0.05) for 20 mg/kg 1 /day 5-Fu. All treatment groups exhibited weight loss with significant tumor suppression compared with the saline group (P < 0.01). However, PAMD also showed the better safety profile than 5-Fu with respect to variation in body weight (P < 0.05), while no significant changes between the body weight of different PAMD dose groups (P > 0.05) [Figure 3]c]. Importantly, the spleen indexes indicates better mice immunity after treated with PAMD than that of 5-Fu (P < 0.01), and no significant difference between PAMD groups (P > 0.05) [Figure 3]d].
|Figure 3: Phenolic alkaloids from Menispermum dauricum (PAMD) inhibits the tumor growth of BxPC-3 xenografts. Randomly grouped nude mice bearing BxPC-3 tumors were treated with saline control (control, C), 5-Fu (20 mg/kg), PAMD (10 mg/kg) or (20 mg/Kg) per day. Tumor volume (a) and body weight (c) were measured every 3 days. The mice were sacrificed until the tumor sizes of the saline control groups reached approximately 1000 mm3. Tumors weight (b) and spleen weights were recorded. (d) The spleen index were determined by the ratio of spleen/ body weight|
Click here to view
Pathological analysis of the BxPC-3 tumor tissues
Hematoxylin and eosin stained tissue sections from each group were distinct with each other [Figure 4]A]. Samples from the saline group showed imbalanced nuclear/plasma ratio and multiple pathologic mitoses. The cancer cells were infiltrative when small glands invaded in a diffuse manner, and the tumor border was not distinct. The 5-Fu treated tumor tissues displayed less pathologic mitoses and invasive cancer cells with slight lymphocytes around the tumor. The tumor tissue was significantly reduced in PAMD treated groups. Minimal necrosis existed in the tumor tissues of low dose group while large areas of necrosis and white cell debris could be noticed in that of the high dose group.
|Figure 4: Pathological analysis of the BxPC-3 tumor tissues. (A) HE staining and (B) immunohistochemistry showed Ki67 expressions in a-d. (a) Control group; (b) 5-fluoro-2, 4 (1 H, 3 H) pyrimidinedione (20 mg/Kg) treated group; (C) Phenolic alkaloids from Menispermum dauricum (PAMD) (10 mg/Kg) treated group; (d) PAMD (20 mg/Kg) treated group. (C) The integrated option density of immunohistochemistry and (D) Western blot pictures showed Ki67 levels in the BxPC-3 tumor tissues and were analyzed by ImagePro Plus. Results are presented as means ± standard deviation of three independent experiments. *P < 0.05: Significant difference; **P < 0.01: Very significant difference|
Click here to view
We next examined the effects of PAMD on cell proliferation in tumor tissues derived from control and drug-treated mice using anti-Ki67 antibody [Figure 4]B-D]. IHC and the Western blot analysis confirmed greater decreases of Ki67 expression in the both PAMD-treated groups compared with the control (P < 0.01) or 5-Fu-treated groups (P < 0.01), and the high dose group downregulated Ki67 expression more effectively than the low-dose group (P < 0.05) tested by both IHC and Western blot, indicating the cell proliferative inhibition of PAMD in BxPC-3 tumor tissues.
Inhibition of Hedgehog signaling pathway by Phenolic alkaloids from Menispermum dauricum downregulates the protein and mRNA levels of Sonic Hedgehog and Gli
As Hh signaling is an essential pathway during embryonic pancreatic development, we also tested the expression of Shh and its downstream transcription factor Gli-1 through IHC [Figure 5]A-D]. ,, The immunostained tissue samples revealed that greater decreases in Shh and Gli-1 expressions in the PAMD-treated group than that of the 5-Fu-treated group compared with the control group in BxPC-3 tumor, indicating that the anti-PC mechanism of PAMD probably act through the blockade of Hh pathway.
|Figure 5: Inhibition of Hedgehog signaling pathway by Phenolic alkaloids from Menispermum dauricum (PAMD). (A) and (C) immunohistochemistry showed Shh and Gli-1 levels in the BxPC-3 tumor tissues. (a) Control group; (b) 5-Fu (20 mg/Kg) treated group; (c) PAMD (10 mg/Kg) treated group; (d) PAMD (20 mg/Kg) treated group. (B) and (D) integrated optical density of immunohistochemistry analyzed by ImagePro Plus. (E) and (F) Western blot showed Sonic Hedgehog (Shh) and Gli-1 protein levels. (G) and (H) qRT PCR of Shh and Gli-1. Results are presented as means ± standard deviation of three independent experiments. *P < 0.05: Significant difference; **P < 0.01: Very significant difference|
Click here to view
To get further insight into the anti-PC mechanism of PAMD, we tested the BxPC-3 tumor tissues with western blot and quantitative RT-PCR. Our data showed that treatment with PAMD results in decreases in Shh and Gli-1 protein levels [Figure 5]E and F]. Similar results were obtained for mRNA expressions. Quantitative RT-PCR showed that the mRNA levels of Shh and Gli-1 was sharply downregulated by 10 and 20 mg/Kg PAMD, while 5-Fu only merely affect the expression of mRNA [Figure 5]G and H].
| Discussion|| |
Hedgehog directed therapeutics offer new hope in the treatment of PC, as it potentially causes tumor regression by intrinsic inhibition of the Hh pathway, decreases the cancer stem population, has a paracrine effect on the tumor stromal cells and improves the therapeutic efficacy of cytotoxic drugs by affecting the desmoplastic fibrotic response and improving chemotherapeutic drug bioavailability.  In the present study, we demonstrated both the in vitro and in vivo antitumor effects of the traditional Chinese medicine PAMD on BxPC-3 PC cells.
The antagonistic efficacy against human PC cells has been demonstrated that PAMD significantly inhibits the proliferation of BxPC-3 cells in a time and dose-dependent manner, with the IC 50 of 2.37, 1.78 and 1.25 μg/mL for 24, 48 and 72 h, respectively [Figure 1]. It also arrests G0/G1 cell cycle progression and induces cell apoptosis detected by flow cytometry [Figure 2]. Furthermore, it has been shown that PAMD displays anti-PC effects in the in vivo animal model [Figure 3]A and B]. The administration of PAMD displayed an inhibitory effect on BxPC-3-derived tumors was more preferable in both the antitumor activity and mouse body weight than that of 5-Fu, one of the most widely used chemotherapy drugs. The pathological analysis showed that PAMD reduces the tumor tissue size, inhibits tumor cell proliferation, induces cancer cell necrosis and reduced the side and toxic effect by protecting mice immune function [Figure 3]C, 3D and [Figure 4]. We have showed that PAMD directly decreases the protein and mRNA levels of Shh and its downstream transcription factor Gli-1 in the BxPC-3 tumor tissues [Figure 5], leading to the blockade of Hh pathway, which may be the primary mechanism mediating the anti-PC activity of PAMD.
Traditional Chinese medicine has been studied as a treatment to the malignant tumor for a long time, with the advantage of synergic effect on multiple oncogenes and overall coordination with preferable safety profile.  In the present study, we confirmed the outstanding anti-PC activity and safety profile of PAMD compared with the traditional chemotherapy drug 5-Fu. These data suggest that the administration of PAMD may be a novel approach to PC treatment, and further investigation should be conducted for the detailed antitumor mechanism of PAMD.
| Conclusion|| |
The traditional Chinese medicine PAMD shows potent anti-tumor effects in BxPC-3 human PC cell both in vitro and in vivo. The treatment of PAMD displayed Hh signaling pathway blockade through decreasing the protein and mRNA levels of Sonic (Hh) and its downstream transcription factor Gli-1, suggesting a promising strategy in treating human PC.
| Acknowledgments|| |
The work is funded by the Natural Science Foundation of China (81373777 and 81173599), Chinese Education Department Foundation for high school doctoral program (20112327120004), Heilongjiang province postdoctoral scientific research program (LBH-Z14196), and Heilongjiang University of Chinese medicine outstanding innovative talents support program (2012 rcd18).
| References|| |
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet 2011;378:607-20.
Onishi H, Katano M. Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer. World J Gastroenterol 2014;20:2335-42.
Ingham PW, McMahon AP. Hedgehog signaling in animal development: Paradigms and principles. Genes Dev 2001;15:3059-87.
Kayed H, Kleeff J, Keleg S, Guo J, Ketterer K, Berberat PO, et al.
Indian hedgehog signaling pathway: Expression and regulation in pancreatic cancer. Int J Cancer 2004;110:668-76.
Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, et al.
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003;425:846-51.
Adolphe C, Narang M, Ellis T, Wicking C, Kaur P, Wainwright B. An in vivo
comparative study of sonic, desert and Indian hedgehog reveals that hedgehog pathway activity regulates epidermal stem cell homeostasis. Development 2004;131:5009-19.
Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, et al.
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003;425:851-6.
Ingham PW, Nakano Y, Seger C. Mechanisms and functions of Hedgehog signalling across the metazoa. Nat Rev Genet 2011;12:393-406.
Jiang J, Hui CC. Hedgehog signaling in development and cancer. Dev Cell 2008;15:801-12.
Xu L, Wang X, Wan J, Li T, Gong X, Zhang K, et al.
Sonic Hedgehog pathway is essential for neuroblastoma cell proliferation and tumor growth. Mol Cell Biochem 2012;364:235-41.
Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, Gervaz P, et al.
Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 2009;1:338-51.
Feng X, Yang S, Liu J, Huang J, Peng J, Lin J, et al
. Electroacupuncture ameliorates cognitive impairment through inhibition of NF-kB-mediated neuronal cell apoptosis in cerebral ischemia-reperfusion injured rats. Mol Med Rep 2013;7:1516-22.
Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M, et al.
Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: A new paradigm for combination therapy in solid cancers. Cancer Res 2007;67:2187-96.
Kalderon D. Transducing the hedgehog signal. Cell 2000;103:371-4.
McMahon AP. More surprises in the Hedgehog signaling pathway. Cell 2000;100:185-8.
Xu Y, An Y, Wang X, Zha W, Li X. Inhibition of the Hedgehog pathway induces autophagy in pancreatic ductal adenocarcinoma cells. Oncol Rep 2014;31:707-12.
Bahra M, Kamphues C, Boas-Knoop S, Lippert S, Esendik U, Schüller U, et al.
Combination of Hedgehog signaling blockage and chemotherapy leads to tumor reduction in pancreatic adenocarcinomas. Pancreas 2012;41:222-9.
Luo H, Peng M, Ye H, Chen L, Peng A, Tang M, et al.
Predictable and linear scale-up of four phenolic alkaloids separation from the roots of Menispermum dauricum
using high-performance counter-current chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:1929-33.
Zhao B, Chen Y, Sun X, Zhou M, Ding J, Zhan JJ, et al.
Phenolic alkaloids from Menispermum dauricum
rhizome protect against brain ischemia injury via regulation of GLT-1, EAAC1 and ROS generation. Molecules 2012;17:2725-37.
Yang Z, Li C, Wang X, Zhai C, Yi Z, Wang L, et al.
Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-kappaB signaling pathway in colon cancer cells. J Cell Physiol 2010;225:266-75.
Wang J, Li Y, Zu XB, Chen MF, Qi L. Dauricine can inhibit the activity of proliferation of urinary tract tumor cells. Asian Pac J Trop Med 2012;5:973-6.
Morton JP, Mongeau ME, Klimstra DS, Morris JP, Lee YC, Kawaguchi Y, et al.
Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci U S A 2007;104:5103-8.
Quint K, Stintzing S, Alinger B, Hauser-Kronberger C, Dietze O, Gahr S, et al.
The expression pattern of PDX-1, SHH, patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer. Pancreatology 2009;9:116-26.
Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A. Hedgehog-Gli1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007;17:165-72.
Kelleher FC. Hedgehog signaling and therapeutics in pancreatic cancer. Carcinogenesis 2011;32:445-51.
Ling CQ, Yue XQ, Ling C. Three advantages of using traditional Chinese medicine to prevent and treat tumor. J Integr Med 2014;12:331-5.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]